“Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial,” by James W. Denham, Chantelle Wilcox, David Joseph, Nigel A. Spry, David S. Lamb, Keen-Hun Tai, John Matthews, Chris Atkinson, Sandra Turner, David Christie, Nirdosh Kumar Gogna, Lizbeth Kenny, Gillian Duchesne, Brett Delahunt, and Patrick McElduff (Vol. 13, No. 12, December 2012, p. 1260-1270).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2812%2970423-0/abstract
